Skip to main content

Month: November 2020

Nano Dimension Prices $60 Million Registered Direct Offering

Sunrise, Florida, Nov. 29, 2020 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading Additively Manufactured Electronics (“AME”)/PE (Printed Electronics) provider, today announced it has entered into definitive agreements with investors for the sale of 11,960,160 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.00 per ADS pursuant to a registered direct offering. The gross proceeds of the offering will be approximately $60 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds for working capital and for other general corporate purposes, and pursuing strategic opportunities, including possible business combination transactions. The closing of the registered direct offering is expected to...

Continue reading

Global Care Capital Evaluates Opportunities in the Crypto Currency and Blockchain Sectors

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 29, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that it is evaluating investment opportunities in the crypto currency and blockchain sectors.In addition to continuing to evaluate opportunities in the healthcare sector, the Company has commenced its due diligence and research procedures in search of new investment opportunities in the crypto currency and blockchain sectors to diversify and strengthen its existing portfolio. The Company’s management team and board of directors will remain the same as...

Continue reading

Xuan Quynh LLC Joins PHILUX Global Funds to Participate in Luxembourg-based Infrastructure Fund for Vietnam and Laos

New York, Nov. 29, 2020 (GLOBE NEWSWIRE) — PHI Group, Inc. (www.phiglobal.com, PHIL), announced today that Xuan Quynh Limited Liability Company, a Vietnamese infrastructure construction and development company, has signed an agreement with PHI Luxembourg Development SA, the mother holding company for PHILUX Global Funds SCA, SICAV-RAIF, to join its “PHILUX Infrastructure Fund” compartment as a new partner in the first-ever Luxembourg-based infrastructure fund initiated for investment in Vietnam and Laos.As one of the fastest growing economies in ASEAN, Vietnam is currently demanding for more foreign financial investment and technical assistance to narrow its infrastructure gap. According to the Global Infrastructure Outlook, Vietnam requires an investment of US$605 billion to meet 83 per cent of its infrastructure goals by 2040....

Continue reading

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

MELBOURNE, Australia and BAAR, Switzerland, Nov. 29, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of hematology.The acquisition of TheraPharm provides Telix with access to a portfolio of patents, technologies, production systems, clinical data and know-how in relation to the use of Molecularly Targeted Radiation (MTR) in hematology and immunology. TheraPharm is developing antibody MTR technology against CD66, a cell surface target highly expressed by neutrophils (a type of white blood cell) and tumor-infiltrating lymphocytes. As such, the technology has...

Continue reading

Sorrento to Participate in the 32nd Piper Sandler Healthcare Investor Conference

SAN DIEGO, Nov. 29, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), is pleased to announce that Dr. Henry Ji, Chairman and CEO, will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference.A pre-recorded presentation is made available to participants and the public, in addition to 1 on 1 virtual meetings with selected investors taking place between 11/30/20 and 12/03/20.Dr. Ji Pre-Recorded Investor Presentation can be accessed at the following Link: https://pipersandler.zoom.us/rec/play/7p6ebIhHbRkmmBaXffNQeGXSsRkhriEV56NBSFVTRQ9IBnxL6C4uvSfjlZXAayBAeewv7zWyCwLtr2XR.qMOgbDXGYEyaZYt2(Note: Link expires 90 days after date of recording).For more information visit www.sorrentotherapeutics.comForward-Looking StatementsThis press release and any statements made for and...

Continue reading

EverQuote Mourns Sudden Passing of Co-Founder & CEO Seth Birnbaum

President Jayme Mendal Appointed CEO and Director CAMBRIDGE, Mass., Nov. 29, 2020 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), today issued the following statement: “It is with immeasurable sadness that we announce that Seth Birnbaum, Co-Founder and CEO, unexpectedly and peacefully passed away yesterday at his home. Seth was a sincere and deeply caring husband, father, friend and colleague. The entire EverQuote team mourns his tragic passing. On behalf of our Board of Directors, management team and employees, we extend our deepest sympathies to Seth’s family. Seth was a genuine, dynamic leader whose remarkable passion, vision and tenacity attracted the world-class team we have in place today, which serves as the foundation for EverQuote’s success. We will be forever grateful for his entrepreneurial spirit and the welcoming...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.